Specific serology for emerging human coronaviruses by protein microarray

Eurosurveillance

Volumn 18, Issue 14, 2013, Pages 2-7

  Reusken, C ^a   Mou, H ^a,b   Godeke, G J ^a,b   van der Hoek, L ^c   Meyer, B ^d   Muller M A ^d   Haagmans, B ^e   de Sousa, R ^a   Schuurman, N ^b   Dittmer, U ^f   Rottier, P ^b   Osterhaus, A ^e   Drosten, C ^d   Bosch, B J ^b   Koopmans, M ^a,e  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF BONN   (Germany)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORONAVIRUS; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROPREVALENCE; VIRUS LOAD;

EID: 84876484686     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.es2013.18.14.20441     Document Type: Article

References (24)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814-20. http://dx.doi.org/10.1056/NEJMoa1211721. PMid:23075143.
2. European Centre for Disease prevention and Control (ECDC). Severe respiratory disease associated with a novel coronavirus. Rapid Risk Assesment. Stockholm: ECDC; Feb 2013. [Accessed 19 Feb 2013]. Available from: http://www.ecdc. europa.eu/en/publications/Publications/novel-coronavirusrapid-risk-assessment-update.pdf
3. European Centre for Disease prevention and Control (ECDC). Confirmed cases of novel coronavirus infection (n=17), reported worldwide as of 26 March 2013. Stockholm: ECDC [Accessed 2 Apr 2013]. Available from: http://www.ecdc. europa.eu/en/healthtopics/Documents/Novel-coronaviruscases-table.pdf
4. Pebody RG. The Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of personto-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill. 2013;18(11):pii=20427. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20427
5. Albarrak AM, Stephens GM, Hewson R, Memish ZA. Recovery from severe novel coronavirus infection. Saudi Med J. 2012;33(12):1265-9. PMid:23232672.
6. Bermingham A, Chand MA, Brown CS, Aarons E, Tong C, Langrish C, et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012;17(40): pii=20290. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20290
7. Pebody RG, Chand MA, Thomas HL, Green HK, Boddington NL, Carvalho C, et al. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill. 2012;17(40): pii=20292. Available from: http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=20292
8. ProMED-mail. Novel coronavirus-East. Med. (7): Saudi Arabia, UK, Germany. ProMED mail. Archive number: 20130221.1554109. 21 Feb 2013. Available from: http://www. promedmail.org/?archiveid=20130221
9. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17(39):pii=20285. Available from: http:// www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20285
10. Corman V, Muller M, Costabel U, Timm J, Binger T, Meyer B, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012;17(49):pii=20334. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20334
11. Palm D, Pereyaslov D, Vaz J, Broberg E, Zeller H, Gross D, et al. Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. Euro Surveill. 2012;17(49):pii=20335. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20335
12. World Health Organization (WHO). Laboratory testing for novel coronavirus. Interim recommendations. Geneva: WHO; 21 Dec 2012. [Accessed 14 Mar 2013]. Available from: http://www.who. int/csr/disease/coronavirus_infections/LaboratoryTestingNove lCoronavirus_21Dec12.pdf
13. Ng LF, Wong M, Koh S, Ooi EE, Tang KF, Leong HN, et al. Detection of severe acute respiratory syndrome coronavirus in blood of infected patients. J Clin Microbiol. 2004;42(1):347-50. http://dx.doi.org/10.1128/JCM.42.1.347-350.2004. PMCid:321706.
14. Chen W, Xu Z, Mu J, Yang L, Gan H, Mu F, et al. Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. J Med Microbiol. 2004;53(Pt 5):435-8. Epub 2004/04/21.
15. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302(5643):276-8. http://dx.doi.org/10.1126/ science.1087139. PMid:12958366.
16. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(41):986-7. PMid:14561956.
17. Novel human Coronavirus HCoV-EMC. Recommendations regarding serological testing. Bonn: Institut für Virologie; 2013. [Accessed 21 Feb 2013]. Available from: http://www. virology-bonn.de/index.php?id=40
18. Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251-4. http://dx.doi.org/10.1038/nature12005. PMid:23486063.
19. Koopmans M, de Bruin E, Godeke GJ, Friesema I, van Gageldonk R, Schipper M, et al. Profiling of humoral immune responses to influenza viruses by using protein microarray. Clin Microbiol Infect. 2012;18(8):797-807. http://dx.doi. org/10.1111/j.1469-0691.2011.03701.x. PMid:22212116.
20. Dijkman R, Jebbink MF, El Idrissi NB, Pyrc K, Muller MA, Kuijpers TW, et al. Human coronavirus NL63 and 229E seroconversion in children. J Clin Microbiol. 2008;46(7):2368-73. http://dx.doi.org/10.1128/JCM.00533-08. PMid:18495857. PMCid:2446899.
21. Dijkman R, Jebbink MF, Gaunt E, Rossen JW, Templeton KE, Kuijpers TW, et al. The dominance of human coronavirus OC43 and NL63 infections in infants. J Clin Virol. 2012;53(2):135-9. http://dx.doi.org/10.1016/j.jcv.2011.11.011. PMid:22188723.
22. Buchholz U, Müller MA, Nitsche A, Sanewski A, Wevering N, Bauer-Balci T, et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 2013;18(8):pii=20406. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20406. PMid:23449231.
23. van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012;3(6):pii: e00473-12. http://dx.doi.org/10.1128/mBio.00473-12. PMid:23170002 PMCid:3509437.
24. Severance EG, Bossis I, Dickerson FB, Stallings CR, Origoni AE, Sullens A, et al. Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population. Clin Vaccine Immunol. 2008;15(12):1805-10. http://dx.doi. org/10.1128/CVI.00124-08. PMid:18945884 PMCid:2593164.